We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Acurian Announces Partnership Agreement with the Society for Clinical Research Sites (SCRS)

Acurian, Inc. announced it has agreed to a two-year partnership with the Society for Clinical Research Sites (SCRS), based in Rockville, MD.
News

Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar

The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment.
News

D.L. Newslow & Associates Joins SafetyChain Software Preferred Partner Program

Partnership will offer world-class FSQA technology and food safety consulting / training services to food and beverage companies.
News

SKTO Secures Additional Acres for the Cultivation of Medical Marijuana

SK3 Group, Inc. has secured an additional 10 acres of real estate in Northern California to develop and manage state-of-the-art growing facilities.
News

Elan Announces Transactions: Decisively Transforming the Company

Upon shareholder approval, the totality of these strategically driven decisions will form a dynamic and unique business foundation for Elan in the years ahead.
News

Global Warming Continues; Most Extreme Projections ‘Less Likely’

Observations of the climate system’s response to rising greenhouse gas levels are consistent with conventional estimates of the long-term ‘climate sensitivity’, despite a “warming pause” over the past decade.
News

SUMO Wrestling Cells Reveal New Protective Mechanism Target for Stroke

Scientists have identified a new target that could increase cell survival.
News

FDA Approves Simponi to Treat Ulcerative Colitis

The U.S. FDA approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.
News

Novozymes Biopharma Helps Innovative Dry Eye Therapy Move into Clinical Trials

A novel ophthalmic solution has recently obtained FDA approval to undergo Phase I/II clinical trials in the United States.
News

The Genome Sequence of Tibetan Antelope Sheds New Light on High-altitude Adaptation

Why Tibetan antelope can live at elevations of 4,000-5,000m on the Qinghai-Tibetan Plateau?
Advertisement